Table 1

Level of Hyaluronate in subgroup of chronic hepatitis B comparing to normal control

Patient Groups

Subgroups

n

Mean ± SD

P value*


Normal control

28

20.4 ± 15.4

Chronic hepatitis B subgroups (degree of fibrosis)

Stage 0–2

54

24.7 ± 31.9

0.69

Stage 3–5

11

309.7 ± 143.5

<0.001

Chronic hepatitis B subgroups (degree of inflammation)

Grade 0–8

54

39.6 ± 74.2

0.10

Grade ≥ 9

11

236.5 ± 188.7

0.003


*Statistical difference between serum hyaluronate of different groups compared with normal controls.

Montazeri et al. BMC Gastroenterology 2005 5:32   doi:10.1186/1471-230X-5-32

Open Data